Skip to main content

ABT-CIP-10306 Antiplatelet Removal and HemocompatIbility Events with the HeartMate 3 Pump

NCT04069156

Antiplatelet Removal and HemocompatIbility Events with the HeartMate 3 Pump

Principal Investigator

Sponsor

Abbott

The purpose of this research study is to understand if aspirin is needed in patients implanted with the HeartMate 3. Patients with devices like the HeartMate 3 take two blood thinner medicines, specifically warfarin and aspirin. Patients implanted with devices like the HeartMate 3 experience both clotting and bleeding complications. Data suggest the HeartMate 3 may not require as much anticoagulation (blood thinners) as are normally used. This study will test if patients need aspirin together with warfarin or just warfarin alone.

This study is currently enrolling.